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doi:10.1016/j.jtcvs.2007.02.037bjective: Complications are associated with increased risk of death. The objective
f this study is to quantify the increased odds of dying from complications after
solated coronary artery bypass grafting surgery.
ethods: We conducted a retrospective cohort study using the New York State
oronary Artery Bypass Grafting Surgery Reporting System for all patients under-
oing isolated coronary artery bypass grafting surgery in New York State who were
ischarged between 1997 and 1999 (51,750 patients; 2.20% mortality). We estimated
he independent effect of individual postoperative complications on in-hospital mortality
fter controlling for patient clinical risk factors and demographics.
esults: The mortality rate for patients without complication was 0.77% versus
6.1% for patients with complications (P  .001). After adjusting for preoperative
isk factors, transmural myocardial infarction (adjusted odds ratio, 7.90; P  .001),
espiratory failure (adjusted odds ratio, 6.02; P  .001), renal failure (adjusted odds
atio, 7.15; P  .001), and stroke within 24 hours (adjusted odds ratio, 4.09; P 
001) were the most strongly associated with mortality.
onclusions: There is a strong association between postoperative complications and
n-hospital mortality. Complications after isolated coronary artery bypass grafting
urgery are associated with a 1.4- to 8-fold increase in the odds of death after
djusting for severity of disease and comorbidities. This information might prove
aluable to hospitals in their efforts to design quality improvement initiatives and
are protocols to improve mortality after coronary artery bypass grafting surgery.
oronary artery disease is the leading cause of death in the United S1
Recent evidence suggests that coronary artery bypass grafting (CABG)
surgery might be the treatment of choice in patients with multivessel
oronary artery disease.2 The release of public and nonpublic CABG outcome re
ards is associated with reductions in CABG mortality rates.3-5 Even greater
eductions in mortality rates might be achievable if hospitals can identify which
omplications are associated with the highest mortality and then focus quality
mprovement efforts on these complications.6
The purpose of this study was to estimate the increased risk of mortality in
atients who have specific complications after CABG surgery. Because higher-risk
atients are both more likely to have complications and to die, it is important to
dequately adjust for severity of disease to quantify the contribution of complica-
ions to mortality.7 Administrative data are not ideally suited to this type of an
ecause they frequently undercode both complications8-11 and comorbidities12,13
nd often do not accurately differentiate between complications and comorbidi-
ies.14,15 We chose to perform this analysis using the New York State 
oronary Artery Bypass Surgery Reporting System (CSRS) database, which con-
ains clinical data on mortality, complications, and preoperative risk factors for all
atients undergoing isolated CABG surgery in NYS.3
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A
CDaterials and Methods
ata
his study uses data from the NYS CSRS and includes all patients
ndergoing isolated CABG surgery in NYS who were discharged
etween 1997 and 1999 (51,750 patients; 2.20% mortality). This
atabase includes information on patient demographics, hospital
nd physician identifiers (encrypted), preoperative risk factors, and
utcomes. These clinical data were collected prospectively at the
ospital level and were then submitted to the NYS Department of
ealth. Audit mechanisms were in place to ensure the accuracy of the
ata.16 This study was exempted from institutional review bo
pproval because it involved the secondary use of pre-existing data.
Information on left ventricular function was missing for ap-
roximately 3% of the patients.* We constructed an imputation
odel17 to predict the ejection fraction by using the STA
STATA Corp, College Station, Tex) “impute” procedure, which is
ased on best-subset regression. Imputed values for patients with
issing ejection fractions were calculated by using the imputation
odel.
Initial exploratory analyses compared the distribution of indi-
idual risk factors for patients without postoperative complications
ith those for patients with at least 1 complication. Continuous
ovariates were compared by using the t test, and categoric co-
ariates were compared by using the 2 test.
odel Development
e first constructed a risk adjustment model to predict in-hospital
ortality that included only preoperative risk factors. Bivariate
nalyses were performed to evaluate the association between mor-
ality and patient preoperative risk factors. Those risk factors with
P value of .20 or less were considered candidate variables for
nclusion in the multivariate prediction model. Forward stepwise
election (P  .05) was used to identify the risk factors that were
ndependently associated with in-hospital mortality. The method of
ractional polynomials18 was used to determine the optimal tra-
ormation for continuous covariates. Robust variance estimator19
ere used to account for the fact that outcomes for patients treated
y the same surgeon were likely to be correlated. We then esti-
ated a second model, based on the first model, which also
ncluded postoperative complications, in addition to previously
dentified preoperative risk factors, as predictor variables for mortal-
ty. Model discrimination was evaluated by using the c-statis20
his final model was used to estimate the independent contribution
f individual postoperative complications to in-hospital mortality.
Abbreviations and Acronyms
ACC  American College of Cardiology
AHA  American Heart Association
CABG coronary artery bypass grafting
CSRS  Coronary Artery Bypass Surgery Reporting
System
NYS  New York State
OR  odds ratiop
For the purpose of this analysis, we defined an ejection fraction of zero as
issing data.
4 The Journal of Thoracic and Cardiovascular Surgery ● July 2All statistical tests were 2-tailed. Data management, regression
nalysis, and regression diagnostics were performed with STATA
E/9.1 software (STATA Corp).
esults
he study sample consisted of 57,150 patients treated by
89 surgeons at 33 hospitals. The preoperative risk factors
or death of the patient groups with and without complica-
ions are compared in Table 1. Compared with pat
ithout complications, patients who went on to sustain 1 or
ore complications were more likely on presentation to be
n congestive heart failure, to be unstable, to be in shock, to
ave undergone cardiopulmonary resuscitation, or to be
ransferred on an emergency basis to the operating room
fter an unsuccessful percutaneous intervention. They were
lso more likely to have significant comorbidities (diabetes,
epatic failure, renal failure, and chronic obstructive pul-
onary disease) and to have more severe atherosclerotic
isease (previous stroke, carotid disease, aortoiliac disease,
emoral-popliteal disease, and calcified aorta). They were
lso more likely to have poor ventricular function (left
entricular ejection fraction 20%) and to have had a
ecent myocardial infarction, previous cardiac surgery, and
eft main coronary artery disease.
Approximately 9% of the patients had 1 or more com-
lications after isolated CABG surgery (Table 1). The 
ality rate for patients with 1 or more complications (16.1%)
as 20 times the mortality of patients with no complications
0.77%, P .001). Complications that were associated with
he highest mortality rates were renal failure (49.4%), sepsis
41.6%), gastrointestinal bleeding (32.6%), and respiratory
ailure (31.2%). After adjusting for preoperative risk fac-
ors, transmural myocardial infarction (adjusted odds ratio
OR], 7.90; P  .001), respiratory failure (adjusted OR,
.02; P .001), renal failure (adjusted OR, 7.15; P .001),
nd stroke within 24 hours (adjusted OR, 4.09; P  .001)
ere most strongly associated with mortality (Table 2). 
ull model is shown in Appendix 1.
iscussion
e find that patients undergoing isolated CABG surgery
ho have 1 or more complications during the postoperative
eriod have between a 1.4- and 8-fold increase in the odds
f mortality compared with patients who do not have com-
lications during the postoperative period. This study is the
rst multicenter study to examine the effect of postoperative
omplications on in-hospital mortality after isolated CABG
urgery. Through a better understanding of the effect of
ndividual complications on mortality, hospitals might be
ble to more effectively focus their quality improvement
ffort on reducing those complications that have the greatest
ffect on mortality.
In theory, a focused approach that targets specific com-
lications through the application of evidence-based clinical
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CDractice guidelines might have a significant effect on com-
lication rates and mortality. Implementation of the Amer-
can College of Cardiology (ACC)/American Heart Associ-
tion (AHA) Practice Guidelines21 might help to reduce t
ncidence of complications and their associated mortality.
ome of the practice guidelines issued by the ACC/AHA
nclude (1) the administration of blood cardioplegia in pa-
ients undergoing urgent/emergency CABG surgery or in
atients with severe left ventricular dysfunction to improve
yocardial protection, (2) the prophylactic use of an intra-
ABLE 1. Preoperative risk factors of patients with and w
No
(n
Demographics
Age (y)
Female sex
BSA (m2)
Hemodynamic status
Unstable
Shock
CPR
Intravenous nitroglycerin within 24 h
CHF, this admission
CHF, previous admission
Malignant ventricular arrhythmia
Emergency transfer to OR after PCI
Comorbidities
Diabetes
Hepatic failure
Renal failure, not on dialysis
Renal failure, on dialysis
Chronic obstructive pulmonary disease
Severity of atherosclerotic disease
Previous stroke
Carotid disease
Aortoiliac disease
Femoral-popliteal disease
Calcified aorta
Ventricular function
Ejection fraction 20
Previous MI, 6 h
Previous MI, 6-23 h
Previous MI, 1-7 d
Previous MI, 7 d
Previous cardiac surgery
1
2
Extent of coronary artery disease
Left main, 70%-89%
Left main, 89%
ll values are percentages unless otherwise stated. Continuous variabl
ompared by using the 2 test. BSA, Body surface area; CPR, cardiopul
ercutaneous coronary intervention; MI, myocardial infarction.ortic balloon pump in patients with severe left ventricular ‡
The Journal of Thoracysfunction as an adjunct to myocardial protection, (3) the
reoperative administration of antibiotics to reduce the risk
f surgical infection, and (4) the postoperative use of anti-
latelet therapy and statin therapy to reduce the risk of
aphenous vein graft closure. Of the 6 recommendations
ssued by the ACC/AHA, however, only 3 are class I
ecommendations† supported by strong evidence.‡ The nar-
“Conditions for which there is evidence and/or general agreement that a given
rocedure or treatment is beneficial, useful, and effective.”21
t any postoperative complications
lications
1,789)
Any complication
(n  5361) P value
7 68.9 .001
2 34.3 .001
99 1.94 .001
14 3.58 .001
35 1.92 .001
15 0.75 .001
2 27.8 .001
1 22.0 .001
60 11.2 .001
00 3.66 .001
69 2.70 .001
0 35.5 .001
08 0.41 .001
10 2.33 .001
54 4.68 .001
4 21.2 .001
32 11.7 .001
6 21.9 .001
64 8.64 .001
42 14.1 .001
40 11.6 .001
63 3.32 .001
73 2.35 .001
77 1.96 .001
2 15.15 .052
9 42.9 .004
39 8.38 .001
44 0.65 .027
92 10.2 .002
57 7.78 .001
re compared by using 2-sample t tests, and categoric variables were
ry resuscitation; CHF, congestive heart failure; OR, operating room; PCI,ithou
comp
 5
65.
28.
1.
1.
0.
0.
19.
11.
7.
2.
0.
30.
0.
1.
1.
15.
6.
13.
4.
8.
5.
1.
0.
0.
14.
40.
5.
0.
8.
5.
es we
mona“Data derived from multiple randomized clinical trials or meta-analyses.”21
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A
CDow scope of these practice guidelines, however, highlights
he critical limitations of the evidence base linking pro-
esses of care to outcomes after cardiac surgery and rein-
orces the need to further expand the list of evidence-based
est practices.
Recent studies have estimated the effect of complications
or Medicare patients undergoing general and orthopedic
urgery7 and for Veterans Administration patients underg-
ng major vascular, general, and orthopedic surgery.6 Using
 case-control design, Silber and colleagues7 found that
edicare patients who experienced a postoperative compli-
ation had 3.4-fold increased risk of mortality within 60
ays of admission compared with patients without a com-
lication. Using data from the National Surgical Quality
mprovement Program database, Khuri and associat6
ound that Veterans Administration patients undergoing ma-
or noncardiac surgery who experienced a postoperative
omplication had their median survival reduced by 69%. A
hird study, based on a single center, reported that cardiac
urgery patients who had complications were more likely to
ie or have a prolonged length of stay.22
In contrast to these other studies, we examined a rela-
ively homogeneous population undergoing only isolated
ABG surgery, as opposed to modeling the effect of com-
lications on mortality for several diverse surgical popula-
ions using a single model. By including several unrelated
rocedures within a single regression model, these other
ABLE 2. Association between mortality and complications
No. Dead, %
ardiac
Transmural myocardial infarction 436 18.6
ulmonary
Respiratory failure 2311 26.9
enal
Renal failure, dialysis 545 49.4
eurological
Stroke, within 24 h 502 19.9
Stroke, 24 h 642 17.3
leeding
Bleeding requiring reoperation 1252 10.2
astrointestinal
GI bleeding 512 32.6
nfection
Deep sternal wound infection 566 12.7
Sepsis 514 41.6
he multivariate logistic regression model is adjusted for the following c
ardiopulmonary resuscitation, intravenous nitroglycerin within 24 hours, c
previous admission, malignant ventricular arrhythmia, and emergency
diabetes, hepatic failure, renal failure not on dialysis, renal failure on dia
isease (previous stroke, carotid disease, aortoiliac disease, femoral-pop
revious myocardial infarction), previous cardiac surgery, and extent of ctudies might not adequately control for preoperative risk c
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2actors because it is unlikely that the effect of these risk
actors on mortality will be the same across different sur-
ical procedures. For example, it is unlikely that a history of
yocardial infarction is associated with the same risk of
eath in a patient undergoing a carotid endarterectomy
ompared with a patient undergoing an open abdominal
ortic aneurysm repair.23
In contrast to Silber and colleagues,7 we were unable t
uantify the effect of the “first” postoperative complication
n outcome because we did not have access to patient charts
nd the CSRS data set does not date postoperative compli-
ations. It is likely that some of the complications included
n our analysis might, in some cases, occur “downstream” of
he first complication. For example, renal failure could be a
rst complication when it occurs because of a low cardiac
utput after terminating cardiopulmonary bypass or it might
e a “delayed” complication when it occurs in the setting of
ultisystem organ failure in a patient with pneumonia and
epsis. However, some of the complications, such as trans-
ural myocardial infarction, stroke, deep sternal wound
nfection, and bleeding requiring reoperation, are likely to
epresent first complications as opposed to delayed compli-
ations. From the standpoint of quality improvement, it is
ore useful to measure the effect of first complications on
ortality because efforts to prevent complications would be
deally targeted at first complications, as opposed to target-
ng delayed complications that occur as a result of a first
re and after adjusting for preoperative clinical risk factors
Bivariate analysis Multivariate analysis
Unadjusted OR P value Adjusted OR P value
10.7 .001 7.90 .001
31.2 .001 6.02 .001
54.7 .001 7.15 .001
11.9 .001 4.09 .001
10.1 .001 3.58 .001
5.51 .001 2.60 .001
24.6 .001 3.49 .001
6.79 .001 1.39 .126
37.9 .001 2.74 .001
tes: age, sex, body surface area, hemodynamic status (unstable, shock,
stive heart failure on this admission, history of congestive heart failure on
sfer to operating room after percutaneous intervention), comorbidities
, and chronic obstructive pulmonary disease), severity of atherosclerotic
disease, and calcified aorta), ventricular function (ejection fraction and
ry artery disease. C-statistic  0.917. OR, Odds ratio; GI, gastrointestinal.befo
ovaria
onge
tran
lysis
litealomplication.
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A
CDOur results should be interpreted with caution, because
his study has several important limitations. First, the data
n complications might not be completely accurate. Previ-
us audits by the NYS Department of Health have found
hat complications are undercoded in the CSRS.§ Second, it
as necessary to impute the values for ejection fraction in
% of the cases. Third, although we believe that our anal-
sis controlled for all potentially relevant confounders, it is
ossible that the absence of unmeasured variables might
ave biased our findings. Finally, this study is based on data
rom NYS and might not be generalizable to other regions
f the United States.
onclusions
n summary, we find that complications after isolated
ABG surgery are associated with a 1.4- to 8-fold increase
n the odds of death after adjusting for severity of disease
nd comorbidities. This information might prove valuable
o hospitals in their efforts to design quality improvement
nitiatives and care protocols to improve mortality after
ABG surgery. Further studies are necessary to develop a
ore comprehensive set of evidence-based guidelines
imed at reducing complication rates for CABG surgery and
o evaluate the benefit of implementing these guidelines
nce they have been developed.
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A
CDppendix 1. Full model
Odds
ratio
P
value
reoperative risk factors
Demographics
Age 1.09 .001
Female sex 1.40 .001
BSA2 0.128 .001
BSA2 ln(BSA) 5.25 .001
Hemodynamic status
Unstable 1.47 .041
Shock 3.25 .001
CPR 4.34 .001
Intravenous nitroglycerin within 24 h 1.34 .001
CHF, this admission 1.22 .028
CHF, previous admission 1.32 .003
Malignant ventricular arrhythmia 1.52 .009
Emergency transfer to OR after PCI 1.19 .532
Comorbidities
Diabetes 1.26 .002
Hepatic failure 2.36 .141
Renal failure, not on dialysis 1.12 .556
Renal failure, on dialysis 4.32 .001
Chronic obstructive pulmonary disease 1.31 .002
Severity of atherosclerotic disease
Previous stroke 1.20 .092
Carotid disease 1.21 .011
Aortoiliac disease 1.70 .001
Femoral-popliteal disease 1.17 .093
Calcified aorta 1.42 .001
Ventricular function
Ejection fraction 0.980 .001
Previous MI, 6 h 2.25 .001
Previous MI, 6-23 h 1.12 .691
Previous MI, 1-7 d 1.45 .001
Previous MI, 7 d 1.22 .023
Previous cardiac surgery
1 2.32 .001
2 4.51 .001
Extent of coronary artery disease
Left main, 70%-89% 1.20 .075
Left main, 89% 1.40 .007
ostoperative complications
Transmural myocardial infarction 7.90 .001
Respiratory failure 6.02 .001
Renal failure, dialysis 7.15 .001
Stroke, within 24 h 4.09 .001
Stroke, 24 h 3.58 .001
Bleeding requiring reoperation 2.60 .001
Gastrointestinal bleeding 3.49 .001
Deep sternal wound infection 1.39 .126
Sepsis 2.74 .001
-statistic  0.917. OR, Odds ratio; BSA, body surface area; CPR, cardio-
ulmonary resuscitation; CHF, congestive heart failure; OR, operating007
